T2 Biosystems Inc. (TTOO)

4.74
0.26 5.20
NASDAQ : Health Technology
Prev Close 5.00
Open 5.03
Day Low/High 4.50 / 5.04
52 Wk Low/High 3.60 / 9.98
Volume 919.31K
Avg Volume 587.30K
Exchange NASDAQ
Shares Outstanding 43.77M
Market Cap 219.28M
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

2 Stocks I'm Buying This Week as Investors Flee Small-Cap Biotechs

2 Stocks I'm Buying This Week as Investors Flee Small-Cap Biotechs

This is why I always have some 'dry powder' to deploy during these temporary hiccups.

Antimicrobials Working Group Highlights Member Company Participation At IDWeek 2018

Antimicrobials Working Group Highlights Member Company Participation At IDWeek 2018

48 Presentations by Coalition Members During the Annual Meeting

Interesting TTOO Put And Call Options For May 2019

Interesting TTOO Put And Call Options For May 2019

Investors in T2 Biosystems Inc saw new options become available this week, for the May 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Consider These Diagnostic Testing Firms

Consider These Diagnostic Testing Firms

Diagnostic firms can have an advantage of recurring revenue streams.

T2 Biosystems Breaks Below 200-Day Moving Average - Notable For TTOO

T2 Biosystems Breaks Below 200-Day Moving Average - Notable For TTOO

In trading on Tuesday, shares of T2 Biosystems Inc crossed below their 200 day moving average of $6.06, changing hands as low as $5.90 per share. T2 Biosystems Inc shares are currently trading down about 2.9% on the day.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

TTOO Crosses Below Key Moving Average Level

TTOO Crosses Below Key Moving Average Level

In trading on Friday, shares of T2 Biosystems Inc crossed below their 200 day moving average of $5.88, changing hands as low as $5.76 per share. T2 Biosystems Inc shares are currently trading off about 5.3% on the day.

How to Play Biotech 'Sell the News' Pattern

How to Play Biotech 'Sell the News' Pattern

Patient investors can profit from small-cap biotech stocks that often slide once positive news comes out.

Oversold Conditions For T2 Biosystems (TTOO)

Oversold Conditions For T2 Biosystems (TTOO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of February 2019 Options Trading For T2 Biosystems (TTOO)

First Week Of February 2019 Options Trading For T2 Biosystems (TTOO)

Investors in T2 Biosystems Inc saw new options become available this week, for the February 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

3 Busted IPOs with 10-Bagger Potential

3 Busted IPOs with 10-Bagger Potential

Verastem Inc., T2 Biosystems Inc. and Resonant Inc. have great long-term growth prospects.

Antimicrobials Working Group Highlights Member Company Participation At ASM Microbe 2018

Antimicrobials Working Group Highlights Member Company Participation At ASM Microbe 2018

88 Presentations by Coalition Members During the Annual Meeting

How to Manage Risk in Biotech Stocks

How to Manage Risk in Biotech Stocks

T2 Biosystems' recent run-up on a positive event provides an important lesson for biotech investors.

Two Antibiotic Plays

Two Antibiotic Plays

They may not get all the attention, but antibiotic drugs are increasingly important.

How to Manage Risk in Biotech

How to Manage Risk in Biotech

T2 Biosystems used the run-up on a positive event - an FDA approval - to raise additional capital.

Interesting TTOO Put And Call Options For July 20th

Investors in T2 Biosystems Inc saw new options begin trading this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TTOO options chain for the new July 20th contracts and identified one put and one call contract of particular interest.

3 of My Favorite Medical Diagnostic Plays

3 of My Favorite Medical Diagnostic Plays

These equities have been in rally mode since April.

First Week Of November 16th Options Trading For T2 Biosystems (TTOO)

Investors in T2 Biosystems Inc saw new options begin trading this week, for the November 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 190 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TTOO Crosses Above Average Analyst Target

In recent trading, shares of T2 Biosystems Inc have crossed above the average analyst 12-month target price of $6.17, changing hands for $6.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Multiple New Studies Demonstrate T2 Biosystems' Diagnostics Improve Detection Of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics

Multiple New Studies Demonstrate T2 Biosystems' Diagnostics Improve Detection Of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics

U.S. and EU studies demonstrate that T2Dx diagnostics enable getting patients on the right therapy faster, improving outcomes, enhancing stewardship, and reducing the cost of care

T2 Biosystems Reports Fourth Quarter And Full-Year 2017 Financial Results And Business Update

T2 Biosystems Reports Fourth Quarter And Full-Year 2017 Financial Results And Business Update

Quarterly Product Revenue Up 125% Year-Over-Year and 76% Over the Prior Quarter

T2 Biosystems Awarded Up To $2 Million By CARB-X To Support Development Of New Tests On The T2Dx Instrument For Drug-Resistant Bacteria

T2 Biosystems Awarded Up To $2 Million By CARB-X To Support Development Of New Tests On The T2Dx Instrument For Drug-Resistant Bacteria

T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria

TTOO Crosses Above Average Analyst Target

TTOO Crosses Above Average Analyst Target

In recent trading, shares of T2 Biosystems Inc have crossed above the average analyst 12-month target price of $5.25, changing hands for $6.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

3 Biotech Stocks I Love for March (Celgene Is One of Them)

3 Biotech Stocks I Love for March (Celgene Is One of Them)

These biotech names are all great buys on dips. Notably Celgene, which is fresh off a terrible trading session.

3 Promising Biotech Stocks to Buy on Dips

3 Promising Biotech Stocks to Buy on Dips

From ANI Pharmaceuticals to T2 Biosystems, these names look good.

TheStreet Quant Rating: D- (Sell)